Bisoprolol responses (PK/PD) in hypertensive patients: A cytochrome P450 (CYP) 2D6 targeted polymorphism study
Background: Bisoprolol is an effective β1-adrenergic blocker, an inter-individual genetic variability was recorded in its response. This study aimed at investigating the association of CYP2D6*2A (rs1080985) and CYP2D6*10 (rs1065852) single-nucleotide polymorphism (SNP) with Bisoprolol response in ca...
Main Authors: | Huda Mohammed Alkreathy, Khlood Mohammed Eid Alsayyid, Jumana Y. Alaama, Kamal Al Ghalayini, Shahid Karim, Ahmed Esmat, Zoheir A. Damanhouri |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Saudi Journal of Biological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319562X20302606 |
Similar Items
-
Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients
by: Sze Wa Chan, et al.
Published: (2021-09-01) -
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
by: Hao Wang, et al.
Published: (2020-01-01) -
Cytochrome P450 2D6 profiles and their relationship with outcomes of primaquine anti-relapse therapy in Australian Defence Force personnel deployed to Papua New Guinea and East Timor
by: Nanhua Chen, et al.
Published: (2019-04-01) -
In vitro study on the effect of peucedanol on the activity of cytochrome P450 enzymes
by: Cun Zhang, et al.
Published: (2021-01-01) -
Identification of novel CYP2D7-2D6 hybrids: non-functional and functional variants
by: Andrea Gaedigk, et al.
Published: (2010-10-01)